Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation

Protein post-translational modification (PTM) is a molecular switch that determines protein diversification and regulates cellular functions, affecting proteins' subcellular localization and three-dimensional structure. Protein palmitoylation is one of the PTMs closely related to tumorigenesis...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxia Liu, Liang Ding, Shitao Li, Lisha Li, Daijun Xing, Xin Zheng, Baochen Zhou
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Heliyon
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025011612
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849774420032225280
author Yuxia Liu
Liang Ding
Shitao Li
Lisha Li
Daijun Xing
Xin Zheng
Baochen Zhou
author_facet Yuxia Liu
Liang Ding
Shitao Li
Lisha Li
Daijun Xing
Xin Zheng
Baochen Zhou
author_sort Yuxia Liu
collection DOAJ
description Protein post-translational modification (PTM) is a molecular switch that determines protein diversification and regulates cellular functions, affecting proteins' subcellular localization and three-dimensional structure. Protein palmitoylation is one of the PTMs closely related to tumorigenesis and tumor progression. Feiyiliu Mixture (FYLM) is an effective herbal prescription in clinical for the treatment of non-small cell lung cancers (NSCLC). It inhibits the expression of AKT and its phosphorylation through multiple mechanisms. However, the activation of protein phosphorylation is closely related to protein translocation mediated by palmitoylation. It is still necessary to investigate whether FYLM induces the palmitoylation of AKT and its underlying mechanism. In the present study, we explored the components and targets of FYLM and found that ZDHHC18 could bind to AKT1. Meanwhile, FYLM reduced ZDHHC18 protein expression (A549, p = 0.0215; H1299, p = 0.0008) and inhibited the activation of AKT1 phosphorylation (A549, p = 0.0002; H1299, p = 0.0003), leading to 30.3 % A549 and 31.3 % H1299 cells apoptosis. Nevertheless, ZDHHC18 is a member of the zinc finger DHHC domain-containing protein family, which mediates the interaction between proteins and membranes to regulate protein palmitoylation. Our study suggests a novel potential mechanism: FYLM suppresses AKT1 phosphorylation to treat NSCLC, which might be associated with ZDHHC18-regulated palmitoylation.
format Article
id doaj-art-e1a56a0f0d644a71ae4f22b9e0d458ac
institution DOAJ
issn 2405-8440
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-e1a56a0f0d644a71ae4f22b9e0d458ac2025-08-20T03:01:42ZengElsevierHeliyon2405-84402025-03-01117e4278010.1016/j.heliyon.2025.e42780Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylationYuxia Liu0Liang Ding1Shitao Li2Lisha Li3Daijun Xing4Xin Zheng5Baochen Zhou6Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, ChinaDepartment of Traditional Chinese Medicine, Qingdao Third People's Hospital, Qingdao 266033, ChinaSecond Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, ChinaQingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266033, ChinaQingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266033, ChinaShandong University of Traditional Chinese Medicine, Jinan 250014, China; Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266033, China; Corresponding author. Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266033, China.Shandong University of Traditional Chinese Medicine, Jinan 250014, China; Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266033, China; Corresponding author. Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, China.Protein post-translational modification (PTM) is a molecular switch that determines protein diversification and regulates cellular functions, affecting proteins' subcellular localization and three-dimensional structure. Protein palmitoylation is one of the PTMs closely related to tumorigenesis and tumor progression. Feiyiliu Mixture (FYLM) is an effective herbal prescription in clinical for the treatment of non-small cell lung cancers (NSCLC). It inhibits the expression of AKT and its phosphorylation through multiple mechanisms. However, the activation of protein phosphorylation is closely related to protein translocation mediated by palmitoylation. It is still necessary to investigate whether FYLM induces the palmitoylation of AKT and its underlying mechanism. In the present study, we explored the components and targets of FYLM and found that ZDHHC18 could bind to AKT1. Meanwhile, FYLM reduced ZDHHC18 protein expression (A549, p = 0.0215; H1299, p = 0.0008) and inhibited the activation of AKT1 phosphorylation (A549, p = 0.0002; H1299, p = 0.0003), leading to 30.3 % A549 and 31.3 % H1299 cells apoptosis. Nevertheless, ZDHHC18 is a member of the zinc finger DHHC domain-containing protein family, which mediates the interaction between proteins and membranes to regulate protein palmitoylation. Our study suggests a novel potential mechanism: FYLM suppresses AKT1 phosphorylation to treat NSCLC, which might be associated with ZDHHC18-regulated palmitoylation.http://www.sciencedirect.com/science/article/pii/S2405844025011612
spellingShingle Yuxia Liu
Liang Ding
Shitao Li
Lisha Li
Daijun Xing
Xin Zheng
Baochen Zhou
Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
Heliyon
title Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
title_full Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
title_fullStr Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
title_full_unstemmed Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
title_short Feiyiliu mixture promotes non-small cell lung cancer cells apoptosis via inhibits ZDHHC18-mediated AKT1 phosphorylation
title_sort feiyiliu mixture promotes non small cell lung cancer cells apoptosis via inhibits zdhhc18 mediated akt1 phosphorylation
url http://www.sciencedirect.com/science/article/pii/S2405844025011612
work_keys_str_mv AT yuxialiu feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT liangding feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT shitaoli feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT lishali feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT daijunxing feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT xinzheng feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation
AT baochenzhou feiyiliumixturepromotesnonsmallcelllungcancercellsapoptosisviainhibitszdhhc18mediatedakt1phosphorylation